In-licensing

Innovative consumer healthcare company seeking OTC products or technologies for development in Psoriasis, or similar, category. Prefer proprietary opportunities with demonstrated safety and efficacy

Wisconsin Pharmacal Company is a leading manufacturer, marketer, and distributor of innovative consumer products, including a range of OTC Psoriasis topical treatments.

Our goal is to expand and innovate our current psoriasis product offering. We are most interested in reviewing product opportunities or technologies for development that can help psoriasis sufferers to safely and effectively relieve and manage their most troublesome symptoms and reduce the frequency and severity of flare ups.

Highest priority will be placed on proprietary opportunities that are patented, or otherwise competitively protected, with demonstrated safety and efficacy for psoriasis treatment, management, or symptom relief.

In addition to our interest in already established psoriasis products with demonstrated market success and OTC status, we have interest in evaluating opportunities for development of novel technologies that can bring innovation to the OTC Psoriasis, or similar dermatological condition, category and offer sufferers aesthetically appealing, effective and safe OTC alternatives or compliments to prescription therapy. Valuable innovations could take many forms, including:
• New delivery formats: hydrogels, foams, patches, sprays, long lasting bioadhesive formulations, etc.

• New actives, excipients or formulations featuring: improved efficacy; fast acting relief; enhanced absorption; quick drying; sustained release properties; non-greasy; no scent or pleasant scent; fast absorbing, etc.

• Natural or botanical formulas with clinical evidence of safety and efficacy

Wisconsin Pharmacal Company has a proven track record of rapidly developing and bringing to market innovative consumer healthcare products based upon both in-licensed and acquired technologies.

Stage of development

Open to all stages of development, but if early stage, then strong preference for patent or patent pending opportunity with data available to substantiate safety and efficacy.

 

Patent information

Strong preference for proprietary opportunities that are patented, patent pending, or otherwise competitively protected.

 

 

Early Stage

Preference is acquisition or license, but open to discuss all forms of potential collaboration including acquisition, licensing, co-development and co-marketing.